Study to Determine the Effects of Human Growth Hormone and Pioglitazone in Overweight, Prediabetic Adults

NCT00352287 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Metabolic Syndrome
Impaired Glucose Tolerance

Interventions

DRUG: Recombinant human growth hormone; pioglitazone

Sponsor

Stanford University